Thus, this study aimed to evaluate the plasma MPO and ANGPTL6 levels in both obese and T2D patients and to assess their association with the biochemical markers of obesity, inflammation, and atherosclerosis. The gene discussed is ANGPTL6; the disease is obesity due to melanocortin 4 receptor deficiency.